Tumor necrosis factor-alpha mediates activation of NF-κB and JNK signaling cascades in retinal ganglion cells and astrocytes in opposite ways

European Journal of Neuroscience

Volumn 40, Issue 8, 2014, Pages 3171-3178

  Dvoriantchikova, Galina ^a   Ivanov, Dmitry ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Glia; Neuronal death; NF B signaling; Tumor necrosis factor alpha

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL; ASTROCYTE; C57BL MOUSE; CELL DEATH; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; MOUSE; RETINA GANGLION CELL; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; CELL DEATH; CELL SURVIVAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; NF-KAPPA B; RETINAL GANGLION CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84910658196     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12710     Document Type: Article

References (37)

1. Barakat, D.J., Dvoriantchikova, G., Ivanov, D. & Shestopalov, V.I. (2012) Astroglial NF-kappaB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury. J. Neurochem., 120, 586-597.
2. Berger, S., Savitz, S.I., Nijhawan, S., Singh, M., David, J., Rosenbaum, P.S. & Rosenbaum, D.M. (2008) Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest. Ophth. Vis. Sci., 49, 3605-3610.
3. Brambilla, R., Dvoriantchikova, G., Barakat, D., Ivanov, D., Bethea, J.R. & Shestopalov, V.I. (2012) Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis. J. Neuroinflamm., 9, 213-225.
4. Bringmann, A., Pannicke, T., Grosche, J., Francke, M., Wiedemann, P., Skatchkov, S.N., Osborne, N.N. & Reichenbach, A. (2006) Muller cells in the healthy and diseased retina. Prog. Retin. Eye Res., 25, 397-424.
5. Challa, S. & Chan, F.K. (2010) Going up in flames: necrotic cell injury and inflammatory diseases. Cell. Mol. Life Sci., 67, 3241-3253.
6. De Simoni, M.G. & Imeri, L. (1998) Cytokine-neurotransmitter interactions in the brain. Biol. Signal. Recept., 7, 33-44.
7. Dvoriantchikova, G., Barakat, D., Brambilla, R., Agudelo, C., Hernandez, E., Bethea, J.R., Shestopalov, V.I. & Ivanov, D. (2009) Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur. J. Neurosci., 30, 175-185.
8. Dvoriantchikova, G., Hernandez, E., Grant, J., Santos, A.R., Yang, H. & Ivanov, D. (2011) The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion. Invest. Ophth. Vis. Sci., 52, 7187-7194.
9. Dvoriantchikova, G., Grant, J., Santos, A.R., Hernandez, E. & Ivanov, D. (2012) Neuronal NAD(P)H oxidases contribute to ROS production and mediate RGC death after ischemia. Invest. Ophth. Vis. Sci., 53, 2823-2830.
10. Dvoriantchikova, G., Degterev, A. & Ivanov, D. (2014a) Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage. Exp. Eye Res., 123, 1-7.
11. Dvoriantchikova, G., Santos, A.R., Saeed, A.M., Dvoriantchikova, X. & Ivanov, D. (2014b) Putative role of protein kinase C in neurotoxic inflammation mediated by extracellular heat shock protein 70 after ischemia-reperfusion. J. Neuroinflamm., 11, 81-100.
12. Fields, R.D. & Stevens-Graham, B. (2002) New insights into neuron-glia communication. Science, 298, 556-562.
13. Hauck, S.M., Suppmann, S. & Ueffing, M. (2003) Proteomic profiling of primary retinal Muller glia cells reveals a shift in expression patterns upon adaptation to in vitro conditions. Glia, 44, 251-263.
14. Herkenham, M., Rathore, P., Brown, P. & Listwak, S.J. (2011) Cautionary notes on the use of NF-kappaB p65 and p50 antibodies for CNS studies. J. Neuroinflamm., 8, 141-150.
15. Ivanov, D., Dvoriantchikova, G., Barakat, D.J., Nathanson, L. & Shestopalov, V.I. (2008) Differential gene expression profiling of large and small retinal ganglion cells. J. Neurosci. Meth., 174, 10-17.
16. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. & Karin, M. (2005) Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120, 649-661.
17. Kim, Y.S., Morgan, M.J., Choksi, S. & Liu, Z.G. (2007) TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell, 26, 675-687.
18. Klement, J.F., Rice, N.R., Car, B.D., Abbondanzo, S.J., Powers, G.D., Bhatt, P.H., Chen, C.H., Rosen, C.A. & Stewart, C.L. (1996) IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol. Cell. Biol., 16, 2341-2349.
19. Kuan, C.Y., Yang, D.D., Samanta Roy, D.R., Davis, R.J., Rakic, P. & Flavell, R.A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron, 22, 667-676.
20. Mak, T.W. & Yeh, W.C. (2002) Signaling for survival and apoptosis in the immune system. Arthritis Res., 4(Suppl 3), S243-S252.
21. Marques-Fernandez, F., Planells-Ferrer, L., Gozzelino, R., Galenkamp, K.M., Reix, S., Llecha-Cano, N., Lopez-Soriano, J., Yuste, V.J., Moubarak, R.S. & Comella, J.X. (2013) TNFalpha induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway. Cell Death Dis., 4, e493-e500.
22. Mattson, M.P. & Meffert, M.K. (2006) Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ., 13, 852-860.
23. McCoy, M.K. & Tansey, M.G. (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflamm., 5, 45-60.
24. Morgan, M.J., Kim, Y.S. & Liu, Z.G. (2008) TNFalpha and reactive oxygen species in necrotic cell death. Cell Res., 18, 343-349.
25. Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.H., Xue, X. & Okumura, K. (2006) Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ., 13, 730-737.
26. Papa, S., Bubici, C., Zazzeroni, F., Pham, C.G., Kuntzen, C., Knabb, J.R., Dean, K. & Franzoso, G. (2006) The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ., 13, 712-729.
27. Pekny, M. & Nilsson, M. (2005) Astrocyte activation and reactive gliosis. Glia, 50, 427-434.
28. Perry, S.W., Dewhurst, S., Bellizzi, M.J. & Gelbard, H.A. (2002) Tumor necrosis factor-alpha in normal and diseased brain: conflicting effects via intraneuronal receptor crosstalk? J. Neurovirol., 8, 611-624.
29. Piccinini, A.M. & Midwood, K.S. (2010) DAMPening inflammation by modulating TLR signalling. Mediat. Inflamm., 2010, 1-20.
30. Sabapathy, K., Jochum, W., Hochedlinger, K., Chang, L., Karin, M. & Wagner, E.F. (1999) Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Develop., 89, 115-124.
31. Son, J.L., Soto, I., Oglesby, E., Lopez-Roca, T., Pease, M.E., Quigley, H.A. & Marsh-Armstrong, N. (2010) Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia, 58, 780-789.
32. Tezel, G. (2008) TNF-alpha signaling in glaucomatous neurodegeneration. Prog. Brain Res., 173, 409-421.
33. Tezel, G. & Wax, M.B. (2000) Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci., 20, 8693-8700.
34. Tezel, G., Li, L.Y., Patil, R.V. & Wax, M.B. (2001) TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest. Ophth. Vis. Sci., 42, 1787-1794.
35. Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. (2014) Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Bio., 15, 135-147.
36. Varela, H.J. & Hernandez, M.R. (1997) Astrocyte responses in human optic nerve head with primary open-angle glaucoma. J. Glaucoma, 6, 303-313.
37. Weston, C.R. & Davis, R.J. (2007) The JNK signal transduction pathway. Curr. Opin. Cell Biol., 19, 142-149.